Literature DB >> 26236798

Intraoperative Functional Mapping and Monitoring during Glioma Surgery.

Taiichi Saito, Yoshihiro Muragaki, Takashi Maruyama, Manabu Tamura, Masayuki Nitta, Yoshikazu Okada.   

Abstract

Glioma surgery represents a significant advance with respect to improving resection rates using new surgical techniques, including intraoperative functional mapping, monitoring, and imaging. Functional mapping under awake craniotomy can be used to detect individual eloquent tissues of speech and/or motor functions in order to prevent unexpected deficits and promote extensive resection. In addition, monitoring the patient’s neurological findings during resection is also very useful for maximizing the removal rate and minimizing deficits by alarming that the touched area is close to eloquent regions and fibers. Assessing several types of evoked potentials, including motor evoked potentials (MEPs), sensory evoked potentials (SEPs) and visual evoked potentials (VEPs), is also helpful for performing surgical monitoring in patients under general anesthesia (GA). We herein review the utility of intraoperative mapping and monitoring the assessment of neurological findings, with a particular focus on speech and the motor function, in patients undergoing glioma surgery.

Entities:  

Year:  2015        PMID: 26236798

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  2 in total

1.  The Relationship Between Stimulation Current and Functional Site Localization During Brain Mapping.

Authors:  Rachel H Muster; Jacob S Young; Peter Y M Woo; Ramin A Morshed; Gayathri Warrier; Sofia Kakaizada; Annette M Molinaro; Mitchel S Berger; Shawn L Hervey-Jumper
Journal:  Neurosurgery       Date:  2021-05-13       Impact factor: 4.654

Review 2.  Critical Neural Networks in Awake Surgery for Gliomas.

Authors:  Masashi Kinoshita; Katsuyoshi Miyashita; Taishi Tsutsui; Takuya Furuta; Mitsutoshi Nakada
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-06-02       Impact factor: 1.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.